Method for the diagnosis, prognosis and treatment of prostate cancer metastasis
US10114022B2 · kind B2 · utility
14Cited by
8References
31Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 9, 2013 |
| Grant date | Oct 30, 2018 |
| Priority date | — |
| Expiry date | Oct 9, 2033 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/56
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a method for the diagnosis or the prognosis of metastasis in prostate cancer which comprises determining if the c-MAF gene is amplified in a primary tumor sample. Likewise, the invention also relates to a method for the diagnosis or the prognosis of metastasis in prostate cancer, as well as to a method for determining the tendency to develop bone metastasis with respect to metastasis in other organs, which, comprise determining the c-MAF expression level. Finally, the invention relates to the use of a c-MAF inhibitor as therapeutic target for treating the prostate cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.